Regen BioPharma replaces auditor after BCRG attestation business acquisition
Regen BioPharma replaced auditor BCRG Group with Simon & Edward LLP on July 13, 2026, following S&E’s June 15 acquisition of BCRG’s attest business.
BCRG’s audit opinions for fiscal 2025 and 2024 were clean, but included a going-concern paragraph citing substantial doubt about the company’s ability to continue.
No accounting or auditing disagreements were reported with BCRG; the only cited reportable issue was previously disclosed material weaknesses in internal controls.
RGBP•
